Nanotechnology in Medical Applications Industry
Description
Wiseguyreports.Com Adds “Nanotechnology in Medical Applications -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database
Nano-enabled medical products began appearing on the market over a decade ago, and some have become best-sellers in their therapeutic categories. The principal areas in which nanomedical products have made an impact are cancer, CNS diseases, cardiovascular disease and infection control. The Summary Table gives estimates of the historical and current markets for these nanomedicine areas with a forecast through 2022.
The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017.
The U.S. market is by far the largest in the global nanomedicine market and is set to continue to dominate the world marketplace; however, other national markets are expected to increase their shares over the next five years.
OUR NEW SAMPLE HAVE BEEN UPDATED NOW WHICH CORRESPOND IN NEW REPORT SHOWING IMPACT OF COVID-19 ON INDUSTRY
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2963548-nanotechnology-in-medical-applications-the-global-market
Reasons for Doing the Study
Nanomedicine is already an established market. Unlike some other potential applications of nanotechnology, which are still largely experimental, nanomedicine has already produced some significant products in which the nano dimension has made a significant contribution to product effectiveness. Now that aspects of the nanomedicine market are established, it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future.
Report Scope:
This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-inflammatories.
Report Includes:
– An overview of the global markets for nanotechnology used in medical applications
– Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
– A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
– Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness
– A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
– Analysis of the market’s dynamics, specifically growth drivers, inhibitors, and opportunities
– Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market
Major Key Players
ABLYNX NV
ABRAXIS BIOSCIENCE (CELGENE)
APHIOS CORP.
BIOFORCE NANOSCIENCES HOLDINGS INC.
BIO-GATEAG
CALANDO PHARMACEUTICALS INC.
C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
ELAN (ALKERMES CORP.)
FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
IGI LABORATORIES (TELIGENT INC.)
KEREOS INC.
KEYSTONE NANO INC.
KLEINDIEK NANOTECHNIKGMBH
LABOPHARM (PALADIN LABS)
LIPLASOME PHARMA APS
MAGFORCE NANOTECHNOLOGIES
MAGNAMEDICS GMBH
MICROFLUIDICS CORP.
MOLECULAR PROFILES (JUNIPER PHARMA SERVICES)
NANOBIO CORP.
NANOBIOTIX
NANOCARRIER CO. LTD
NANOCOPOEIA, INC.
NANOCYTE INC.
NANOLOGIX INC.
NANOMED PHARMACEUTICALSINC.
NANOMIX INC.
NANOPHARM AG
NANOSPECTRA BIOSCIENCESINC.
NANOSPHERE INC. (LUMINEX CORP.)
NANOSTRUCTURES INC.
NANOSYN INC.
NANOTHERAPEUTICS INC.
NANOTROPE INC.
NANOVIRICIDES INC
NUCRYST PHARMACEUTICALS
NUTRALEASE
ORTHOVITA INC. (STRYKER CORP.)
PIONEER SURGICAL TECHNOLOGY (RTI SURGICAL)
PSIVIDA LTD.
SOLUBEST LTD
STARPHARMA
TECANGROUP LTD.
TRANSGENEX NANOBIOTECH INC.
Report Detail’s @ https://www.wiseguyreports.com/reports/2963548-nanotechnology-in-medical-applications-the-global-market
Table of Contents
Chapter 1: Introduction …………………………………………………………………………….. 1
Chapter 2: Summary and Highlights …………………………………………………………….. 6
Chapter 3: Nanomedicine ……………………………………………………………………….. 17
Chapter 4: Markets for Nanomedicine ………………………………………………………. 55
Chapter 5: The Nanomedicine Industry ……………………………………………………… 72
Continued…
Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
NOTE : Our final report have added the analysis of the impact of COVID-19 on this industry, Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.